We are live on ! Find out more
ROTUOC

Regents of the University of California Portfolio holdings

AUM $4.36B
1-Year Est. Return 33.89%
This Fund
S&P 500
This Quarter Est. Return
-5.1%
1 Year Est. Return
+33.89%
3 Year Est. Return
+86.09%
5 Year Est. Return
+63.96%
10 Year Est. Return
+870.04%
AUM
$671M
AUM Growth
+$481M
Cap. Flow
+$531M
Cap. Flow %
79.06%
Top 10 Hldgs %
98.08%
Holding
35
New
6
Increased
1
Reduced
2
Closed
5

Top Buys

Rank Stock Value
1
GH icon
Guardant Health
GH
+$6.5M
2
REAL icon
The RealReal
REAL
+$1.97M
3
HCAT icon
Health Catalyst
HCAT
+$370K
4
ZM icon
Zoom
ZM
+$170K

Top Sells

Rank Stock Value
1
CNST
Constellation Pharmaceuticals, Inc.
CNST
+$8.69M
2
XYZ
Block Inc
XYZ
+$4.32M
3
CRWD icon
CrowdStrike
CRWD
+$2.89M
4
UBER icon
Uber
UBER
+$1.67M
5
MDB icon
MongoDB
MDB
+$1.51M

Sector Composition

Rank Sector Weight
1 Healthcare 16.47%
2 Consumer Staples 0.91%
3 Financials 0.6%
4 Communication Services 0.32%
5 Technology 0.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALLO icon
1
Allogene Therapeutics
ALLO
$704M
$47.2M 7.03%
2,350,930
CNST
2
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$47.1M 7.01%
1,497,406
-250,000
-14% -$8.69M
GH icon
3
Guardant Health
GH
$21.6B
$11.3M 1.68%
162,162
+84,666
+109% +$6.5M
EL icon
4
Estee Lauder
EL
$31.7B
$5.32M 0.79%
33,400
APD icon
5
Air Products & Chemicals
APD
$68B
$2.04M 0.3%
10,200
MRK icon
6
Merck
MRK
$332B
$1.66M 0.25%
22,637
BRK.B icon
7
Berkshire Hathaway Class B
BRK.B
$1.09T
$1.47M 0.22%
8,043
SPGI icon
8
S&P Global
SPGI
$122B
$1.47M 0.22%
6,000
NTLA icon
9
Intellia Therapeutics
NTLA
$1.67B
$1.36M 0.2%
111,440
XOM icon
10
ExxonMobil
XOM
$656B
$1.28M 0.19%
33,600
REAL icon
11
The RealReal
REAL
$1.35B
$1.01M 0.15%
+144,514
New +$1.97M
VZ icon
12
Verizon
VZ
$198B
$953K 0.14%
17,735
XYZ
13
Block Inc
XYZ
$48.5B
$936K 0.14%
17,874
-63,139
-78% -$4.32M
PFE icon
14
Pfizer
PFE
$153B
$902K 0.13%
29,138
KO icon
15
Coca-Cola
KO
$377B
$797K 0.12%
18,000
GBT
16
DELISTED
Global Blood Therapeutics, Inc.
GBT
$712K 0.11%
13,928
TXN icon
17
Texas Instruments
TXN
$253B
$650K 0.1%
6,500
T icon
18
AT&T
T
$167B
$632K 0.09%
28,715
DIS icon
19
Walt Disney
DIS
$179B
$580K 0.09%
6,000
HON icon
20
Honeywell
HON
$73.9B
$565K 0.08%
4,481
WFC icon
21
Wells Fargo
WFC
$266B
$520K 0.08%
18,106
MRSH
22
Marsh
MRSH
$89.4B
$450K 0.07%
5,200
GE icon
23
GE Aerospace
GE
$375B
$318K 0.05%
8,041
HCAT icon
24
Health Catalyst
HCAT
$134M
$317K 0.05%
+12,126
New +$370K
ZM icon
25
Zoom
ZM
$31B
$251K 0.04%
+1,719
New +$170K

Similar funds

Regents of the University of California's Q1 2020 Portfolio in Review

As of Q1 2020, Regents of the University of California held 35 positions worth $671M, up 254% from $190M the previous quarter. Its ten largest holdings account for 98% of the portfolio.

Regents of the University of California deployed $531M of net new capital in Q1 2020, opening 6 new positions and adding to 1 existing holding. Its largest new stake was The RealReal: 144,514 shares worth $1.01M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 82% a quarter earlier, followed by Consumer Staples and Financials.

On the sell side, the largest reduction was Constellation Pharmaceuticals, Inc., an estimated $8.69M trimmed.

  • Regents of the University of California's largest Q1 2020 buy was The RealReal: 144,514 shares worth $1.01M.
  • Regents of the University of California added most to Guardant Health in Q1 2020, an estimated $6.5M increase.
  • Regents of the University of California's biggest Q1 2020 reduction was Constellation Pharmaceuticals, Inc., cutting an estimated $8.69M.
  • Regents of the University of California fully exited CrowdStrike in Q1 2020, selling an estimated $2.89M.
  • Regents of the University of California's ten largest holdings make up 98% of its $671M portfolio in Q1 2020.
  • Regents of the University of California opened 6 new positions and closed 5 in Q1 2020.
  • Regents of the University of California's portfolio value rose 254% quarter-over-quarter to $671M.

Based on Regents of the University of California's 13F filing for Q1 2020, filed 24 Apr 2020.